n-vinyl-2-pyrrolidinone has been researched along with Bilharziasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aires, A; Albuquerque, M; Alves, L; Brayner, F; da Silva, P; Gomes, T; Lima, MDC; Neto, PR; Oliveira, J; Paulino, S; Rabello, M; Rocha, T; Santos, L; Santos, V; Silva, R | 1 |
| Camus, D; Capron, A; Fischer, E; Santoro, F | 1 |
2 other study(ies) available for n-vinyl-2-pyrrolidinone and Bilharziasis
| Article | Year |
|---|---|
Development of solid dispersions based on 3- (2,6-difluorobenzyl) -5- (5-bromo-1H-indol-3-ylmethylene) thiazolidine-2,4-dione for schistosomicidal treatment.
Topics: Humans; Polymers; Povidone; Schistosomiasis; Schistosomicides; Spectroscopy, Fourier Transform Infrared; Thiazolidines; X-Ray Diffraction | 2023 |
Schistosoma mansoni: autoantibodies and polyclonal B cell activation in infected mice.
Topics: Animals; Antibody Formation; Antigen-Antibody Complex; Antilymphocyte Serum; Autoantibodies; B-Lymphocytes; Liver; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Povidone; Schistosoma mansoni; Schistosomiasis; Spleen | 1981 |